A Link from the Cause: CMT: Charcot-Marie-Tooth & The Hereditary Neuropathy Foundation
Back to Cause
Ipsen and PHARNEXT Conclude an Exclusive Research, Development and Mar... | Financial 24
Posted by
Regulatory News: Ipsen , an innovation-driven global pharmaceutical Group and Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments, today announced...
2
people
viewed
40%
Viewer Goal:
5
people
Help spread this important message:
Very interesting - pharma is getting involved in CMT research!
1 person
has
sent this to friends:
Get More Involved!
Help the cause:
| Members: | 1,544 |
|---|---|
| Mission: | To conquer this disease. We need to be positive, proactive and optimistic. HNF is raising money for research to develop gene and other successful therapies to treat and CURE this disease. |